Sleep Infra-slow Oscillations III
Sleep-ISO III
1 other identifier
interventional
17
1 country
1
Brief Summary
In young healthy subjects, we will apply sensory stimuli at specific times during sleep to evaluate the probability that the stimulus evokes an arousal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Oct 2018
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2018
CompletedFirst Posted
Study publicly available on registry
September 24, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedNovember 8, 2023
November 1, 2023
4.8 years
September 20, 2018
November 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Arousal probability
Number stimuli that are followed by an EEG arousal divided by the total number of stimuli
8 hours
Interventions
Sensory stimulation during sleep
Eligibility Criteria
You may qualify if:
- Willingness to participate and written informed consent
- Aged 20 to 40 years at the time of screening
- Body mass index (BMI) ≤ 30
You may not qualify if:
- Pregnancy or breast feeding at the time of screening
- Sleep related breathing disorders
- Any other sleep related breathing disorder according to AASM criteria
- Current history of psychiatric disorders according to DSM-V
- Current chronic treatment that may affect sleep
- Any significant neurological disorder or other medical disease that may affect sleep
- Any unstable medical condition
- Any clinically significant sleep disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neurocenter of Southern Switzerland
Lugano, Canton Ticino, 6903, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Stephany Fulda, PhD
Neurocenter of Southern Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Stephany Fulda, Principal Investigator
Study Record Dates
First Submitted
September 20, 2018
First Posted
September 24, 2018
Study Start
October 1, 2018
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
November 8, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
The data and metadata generating in this project will be deposited onto existing public repositories.